113 related articles for article (PubMed ID: 14530350)
1. Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidis.
Davenport V; Guthrie T; Findlow J; Borrow R; Williams NA; Heyderman RS
J Immunol; 2003 Oct; 171(8):4263-70. PubMed ID: 14530350
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B.
Davenport V; Groves E; Horton RE; Hobbs CG; Guthrie T; Findlow J; Borrow R; Naess LM; Oster P; Heyderman RS; Williams NA
J Infect Dis; 2008 Sep; 198(5):731-40. PubMed ID: 18636953
[TBL] [Abstract][Full Text] [Related]
3. Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.
Jordens JZ; Williams JN; Jones GR; Christodoulides M; Heckels JE
Infect Immun; 2004 Nov; 72(11):6503-10. PubMed ID: 15501781
[TBL] [Abstract][Full Text] [Related]
4. IgA1 antibodies specific for outer membrane protein PorA modulate the interaction between Neisseria meningitidis and the epithelium.
Horton RE; Vidarsson G; Virji M; Williams NA; Heyderman RS
Microb Pathog; 2009 May; 46(5):253-60. PubMed ID: 19486642
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunological responses to recombinant Porin A protein (rPoA) from native strains of Neisseria meningitidis serogroups A and B using OMV as an adjuvant in BALB/c mice.
Afrough P; Bouzari S; Mousavi SF; Asadi Karam MR; Vaziri F; Fateh A; Behrouzi A; Malekan M; Siadat SD
Microb Pathog; 2017 Nov; 112():209-214. PubMed ID: 28942175
[TBL] [Abstract][Full Text] [Related]
6. Neisseria lactamica selectively induces mitogenic proliferation of the naive B cell pool via cell surface Ig.
Vaughan AT; Brackenbury LS; Massari P; Davenport V; Gorringe A; Heyderman RS; Williams NA
J Immunol; 2010 Sep; 185(6):3652-60. PubMed ID: 20709949
[TBL] [Abstract][Full Text] [Related]
7. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine.
van der Voort ER; van Dijken H; Kuipers B; van der Biezen J; van der Ley P; Meylis J; Claassen I; Poolman J
Infect Immun; 1997 Dec; 65(12):5184-90. PubMed ID: 9393814
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study.
Perrett KP; McVernon J; Richmond PC; Marshall H; Nissen M; August A; Percell S; Toneatto D; Nolan T
Vaccine; 2015 Sep; 33(39):5217-24. PubMed ID: 26232542
[TBL] [Abstract][Full Text] [Related]
9. A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.
Marsay L; Dold C; Green CA; Rollier CS; Norheim G; Sadarangani M; Shanyinde M; Brehony C; Thompson AJ; Sanders H; Chan H; Haworth K; Derrick JP; Feavers IM; Maiden MC; Pollard AJ
J Infect; 2015 Sep; 71(3):326-37. PubMed ID: 25982025
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of pathogenic Neisseria meningitidis serogroup B serosubtypes in Malta: implications for introducing PorA based vaccines.
Pace D; Cuschieri P; Galea Debono A; Attard-Montalto S
Vaccine; 2008 Nov; 26(47):5952-6. PubMed ID: 18801401
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
[TBL] [Abstract][Full Text] [Related]
12. Antibody and memory CD4(+) T-cell responses after meningococcal disease.
Cruz AC; Figueredo BS; Souza SL; Rebelo MC; Carvalho AG; Milagres LG
Vaccine; 2014 Sep; 32(40):5145-8. PubMed ID: 25090647
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.
Evans CM; Pratt CB; Matheson M; Vaughan TE; Findlow J; Borrow R; Gorringe AR; Read RC
Clin Infect Dis; 2011 Jan; 52(1):70-7. PubMed ID: 21148522
[TBL] [Abstract][Full Text] [Related]
14. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage.
Vaughan AT; Gorringe A; Davenport V; Williams NA; Heyderman RS
J Immunol; 2009 Feb; 182(4):2231-40. PubMed ID: 19201877
[TBL] [Abstract][Full Text] [Related]
15. Porin A-specific antibody avidity in patients who are convalescing from meningococcal B disease.
Vermont CL; van Dijken HH; de Groot R; van den Dobbelsteen GP
Pediatr Res; 2005 Jul; 58(1):149-52. PubMed ID: 15774845
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Finney M; Vaughan T; Taylor S; Hudson MJ; Pratt C; Wheeler JX; Vipond C; Feavers I; Jones C; Findlow J; Borrow R; Gorringe A
Hum Vaccin; 2008; 4(1):23-30. PubMed ID: 17921703
[TBL] [Abstract][Full Text] [Related]
17. In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica.
Sánchez S; Troncoso G; Criado MT; Ferreirós C
Vaccine; 2002 Jul; 20(23-24):2957-63. PubMed ID: 12126908
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.
Zhu D; Barniak V; Zhang Y; Green B; Zlotnick G
Vaccine; 2006 Jun; 24(26):5420-5. PubMed ID: 16621173
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa.
Davenport V; Groves E; Hobbs CG; Williams NA; Heyderman RS
Cell Microbiol; 2007 Apr; 9(4):1050-61. PubMed ID: 17166235
[TBL] [Abstract][Full Text] [Related]
20. Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification.
Zhang L; Wen Z; Lin J; Xu H; Herbert P; Wang XM; Mehl JT; Ahl PL; Dieter L; Russell R; Kosinski MJ; Przysiecki CT
Vaccine; 2016 Jul; 34(35):4250-4256. PubMed ID: 27269057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
